# Progress in the Expression, Purification, and Characterization of Recombinant Collagen

**Authors:** Youlin Deng, Jiyao Kang, Xiaoqun Duan, Yingjun Kong, Weiquan Xie, Dongjie Lei, Tingchun Wang, Guifeng Zhang

PMC · DOI: 10.3390/bioengineering13020159 · Bioengineering · 2026-01-28

## TL;DR

This review summarizes advances in making and testing recombinant collagen, highlighting its benefits and potential uses in medicine and cosmetics.

## Contribution

The paper provides a comprehensive overview of expression systems, purification methods, and characterization techniques for recombinant collagen.

## Key findings

- Recombinant collagen offers advantages like high bioactivity and low immunogenicity, suitable for biomaterials and skincare.
- Various expression systems like E. coli and Pichia pastoris are compared for efficiency and cost-effectiveness.
- Purification methods such as affinity and ion-exchange chromatography are analyzed for their effectiveness.

## Abstract

Synthesized by expressing natural collagen sequences in specific hosts, recombinant collagen exhibits multiple advantages, encompassing a higher content of bioactive domains, enhanced antioxidant activity, the absence of viral pathogens, favorable hydrophilicity, reproducible production, and low immunogenicity. Consequently, it has found extensive use in applications ranging from biomaterials and pharmaceuticals to skincare. This review systematically explores various expression systems for recombinant collagen, including those utilizing Escherichia coli, Pichia pastoris, plants, insect baculovirus, and mammalian cells. It provides a detailed comparison of their differences and commonalities in terms of production efficiency, post-translational modification capability, and cost-effectiveness. Key separation and purification techniques for recombinant collage-notably precipitation, affinity chromatography, ion-exchange chromatography, and gel filtration chromatography are further introduced, with an in-depth analysis of the applicable scenarios and purification outcomes for each method. Finally, the review comprehensively summarizes the characterization methods for both the physicochemical properties and biological functions of recombinant collagen. For physicochemical properties, techniques covered include scanning electron microscopy, micro-differential thermal analysis, circular dichroism spectroscopy, SDS-PAGE, mass spectrometry, and Fourier-transform infrared spectroscopy. For biological functions, the focus is on its roles and the corresponding assessment methods in processes such as cell proliferation, migration, adhesion, and wound healing. Building upon this comprehensive overview, current challenges facing recombinant collagen are identified, and future directions are proposed, emphasizing the need to reduce R&D costs, refine testing methods for cosmetic products, and improve safety evaluation protocols to advance the field.

## Linked entities

- **Proteins:** COL3A1 (collagen type III alpha 1 chain)
- **Species:** Escherichia coli (taxon 562)

## Full-text entities

- **Genes:** COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281] {aka EDS4A, EDSVASC, PMGEDSV}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, IGKV7-3 (immunoglobulin kappa variable 7-3 (pseudogene)) [NCBI Gene 28905] {aka B1, IGKV73}, COL17A1 (collagen type XVII alpha 1 chain) [NCBI Gene 1308] {aka BA16H23.2, BP180, BPA-2, BPAG2, ERED, JEB4}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}, KRT14 (keratin 14) [NCBI Gene 3861] {aka CK14, EBS1, EBS1A, EBS1B, EBS1C, EBS1D}, MT2A (metallothionein 2A) [NCBI Gene 4502] {aka MT-2, MT-II, MT2}, PLOD3 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 3) [NCBI Gene 8985] {aka BCARD, LH3}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, ATP6V0A2 (ATPase H+ transporting V0 subunit a2) [NCBI Gene 23545] {aka A2, ARCL, ARCL2A, ATP6A2, ATP6N1D, J6B7}, ITGA1 (integrin subunit alpha 1) [NCBI Gene 3672] {aka CD49a, VLA1}, BCL2A1 (BCL2 related protein A1) [NCBI Gene 597] {aka ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1}
- **Diseases:** oral mucositis (MESH:D013280), weight loss (MESH:D015431), blood coagulation (MESH:D001778), skin defect (MESH:D012868), liver hemorrhage (MESH:D017093), blood loss (MESH:D016063), calcification (MESH:D002114), diabetic (MESH:D003920), injury to (MESH:D014947), burn (MESH:D002056), dystrophic epidermolysis bullosa (MESH:D016108), bleeding (MESH:D006470)
- **Chemicals:** hydroxyapatite (MESH:D017886), MTT (MESH:C070243), amino acid (MESH:D000596), Na2SO4 (MESH:C012036), 4-hydroxyproline (MESH:D006909), disulfide (MESH:D004220), Amide II (-), guanidine hydrochloride (MESH:D019791), H (MESH:D006859), (NH4)2SO4 (MESH:D000645), IPTG (MESH:D007544), C (MESH:D002244), N (MESH:D009584), His (MESH:D006639), nickel (MESH:D009532), Zn (MESH:D015032), oxygen (MESH:D010100), salt (MESH:D012492), chitosan (MESH:D048271), NaCl (MESH:D012965), proline (MESH:D011392), metal (MESH:D008670), SDS (MESH:D012967), acetic acid (MESH:D019342), imidazole (MESH:C029899), water (MESH:D014867), CCK-8 (MESH:D012844)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Komagataella phaffii GS115 (strain) [taxon 644223], Drosophila melanogaster (fruit fly, species) [taxon 7227], Bombyx mori (domestic silkworm, species) [taxon 7091], Bos taurus (bovine, species) [taxon 9913], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Mus musculus (house mouse, species) [taxon 10090], Yarrowia lipolytica (species) [taxon 4952], Ogataea angusta (species) [taxon 870730], Bacillus subtilis (species) [taxon 1423], Escherichia coli (E. coli, species) [taxon 562], Nicotiana tabacum (American tobacco, species) [taxon 4097], Lactococcus lactis (species) [taxon 1358], Sus scrofa (pig, species) [taxon 9823], Ovis aries (domestic sheep, species) [taxon 9940], Komagataella pastoris (species) [taxon 4922], Kluyveromyces marxianus (species) [taxon 4911]
- **Cell lines:** HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), HLC — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_B1NU), SMD1168 — Homo sapiens (Human), Huntington's disease, Finite cell line (CVCL_1H37), HT1080 — Homo sapiens (Human), Fibrosarcoma, Cancer cell line (CVCL_0317), BHK21 — Mesocricetus auratus (Golden hamster), Spontaneously immortalized cell line (CVCL_RQ70), KM71 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Transformed cell line (CVCL_Y114), MC100 — Equus caballus (Horse), Transformed cell line (CVCL_C4M8), BaP4H — Homo sapiens (Human), Transformed cell line (CVCL_B3EU), SMG — Mus musculus (Mouse), Hybridoma (CVCL_B6FM), GS115 — Homo sapiens (Human), Spinocerebellar ataxia type 1, Induced pluripotent stem cell (CVCL_ZA12), L929 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_AR58), L593 — Homo sapiens (Human), Mucopolysaccharidosis type IVA, Finite cell line (CVCL_9W76), CHO — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_0213), Sf9 — Spodoptera frugiperda (Fall armyworm), Spontaneously immortalized cell line (CVCL_0549)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938472/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938472/full.md

## References

129 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938472/full.md

---
Source: https://tomesphere.com/paper/PMC12938472